Search research articles
Contact Us
Filters
Showing results (301-310 of 327) with videos related to
Page
of 33
Sort By:
Journal of the National Cancer Institute
|
July 19, 1989
Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine
D Goldstein, K M Sielaff, B E Storer, et al.
Cancer Research
|
December 1, 1984
American cancer society Phase I trial of naturally produced beta-interferon
M J Hawkins, S E Krown, E C Borden, et al.
International Journal of Cancer
|
December 15, 1974
Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly
E C Borden, W A Carter, L L Sensenbrenner, et al.
Nature
|
October 8, 2010
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
Xiaoxia Z West, Nikolay L Malinin, Alona A Merkulova, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)
Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer
R W Byhardt, L Vaickus, P L Witt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 1997
Concepts of fever: recent advances and lingering dogma
P A Mackowiak, J G Bartlett, E C Borden, et al.
Biochemical and Biophysical Research Communications
|
September 6, 2005
Proteomic identification of proteins conjugated to ISG15 in mouse and human cells
Nadia V Giannakopoulos, Jiann-Kae Luo, Vladimir Papov, et al.
The Journal of Biological Chemistry
|
December 1, 2019
Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL
Mamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1993
A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancer
C Gambacorti-Passerini, J A Hank, M R Albertini, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 327) with videos related to
Sort By:
Page
of 33
Journal of the National Cancer Institute
|
July 19, 1989
Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine
D Goldstein, K M Sielaff, B E Storer, et al.
Cancer Research
|
December 1, 1984
American cancer society Phase I trial of naturally produced beta-interferon
M J Hawkins, S E Krown, E C Borden, et al.
International Journal of Cancer
|
December 15, 1974
Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly
E C Borden, W A Carter, L L Sensenbrenner, et al.
Nature
|
October 8, 2010
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
Xiaoxia Z West, Nikolay L Malinin, Alona A Merkulova, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)
Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer
R W Byhardt, L Vaickus, P L Witt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 1997
Concepts of fever: recent advances and lingering dogma
P A Mackowiak, J G Bartlett, E C Borden, et al.
Biochemical and Biophysical Research Communications
|
September 6, 2005
Proteomic identification of proteins conjugated to ISG15 in mouse and human cells
Nadia V Giannakopoulos, Jiann-Kae Luo, Vladimir Papov, et al.
The Journal of Biological Chemistry
|
December 1, 2019
Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL
Mamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1993
A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancer
C Gambacorti-Passerini, J A Hank, M R Albertini, et al.
Page
of 33